US agency accuses L'Oreal of misleading marketing

September 12, 2012

US regulators accused French cosmetics giant L'Oreal of misleading claims in marketing its Lancome line of anti-aging products, according to a letter released Tuesday.

In the letter, addressed to the president of L'Oreal-owned Lancome USA, the said some Lancome products advertised online carry claims that "are intended to affect the structure or any function of the , rendering them drugs" under US law.

The products under scrutiny include the Genifique Youth Activating Concentrate, which claims to boost "the activity of genes and stimulates the production of youth proteins," according to the letter.

Another singled out is the Genifique Repair Youth Activating Night Cream, which claims to boost "the activity of ."

Lancome has 15 days to respond to the FDA warning with specific steps it has taken to correct the violations, according to the letter dated Friday.

"We request that you take prompt action to correct all violations associated with your products, including the violations identified in this letter," wrote the FDA's Michael W. Roosevelt of the Center for and Applied Nutrition. "Failure to do so may result in enforcement action without further notice."

L'Oreal is the world's largest cosmetics maker.

Related Stories

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.